Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Price Analysis
View:
Post by TACT on Oct 22, 2015 4:51pm

Price Analysis

Thought those of you who like price chart analysis might enjoy this link, traders cheat sheet
https://www.barchart.com/cheatsheet.php?sym=CXR.TO
Comment by TechTarget on Oct 22, 2015 5:03pm
Beauty isn't it?  Shows all the big resistance up higher than 92 and we're all past any short term turning points. You need TA but also need to appreciate that fundamentals is great fuel for this rocket!  Who need penny stocks for high growth investments! LOL  
Comment by TACT on Oct 22, 2015 5:55pm
I like that RSI14 had been oversold below 30, generally when it rises/closes past 30 its a long signal. RSI 30 level equates to about $37 level. RSI 50 equates to about $59 and overbought above RSI 70 level equates to $111. Ok, that doesn't seem a likely rebound 111 but certainly the 50% 'average' closing price strength of past 14 days as measured by RS14 and $59 seems doable. Here it ...more  
Comment by Tobuyornot on Oct 22, 2015 6:27pm
I'd settle for $59 before Xmas!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities